Klaus-Henning Kahl - Concepedia

Author

Klaus-Henning Kahl

University Hospital Augsburg ORCID

Also Known As

H KAHL, H Kahl, H. Kahl, Hanning Kahl, Henning K. Kahl, Henning Kahl, K Henning Kahl, K-H. Kahl, K. H. Kahl, K. Kahl

Publications

986

Citations

H-Index

Concepts

All Affiliations

University Hospital Augsburg Heidelberg University University Hospital Heidelberg University Hospital Schleswig-Holstein University Hospital of Zurich

About

Klaus-Henning Kahl is an author at University Hospital Augsburg specializing in medicine, radiation therapy, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	549
2	Health Sciences	7	7	445
3	Radiation Medicine	5	5	299
4	Pulmonary Disease	1	1	45
5	Pulmonary Medicine	1	1	47

Klaus-Henning Kahl

Publications

754

Citations

H-Index

Page 1

	Year	Citations
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—A pooled analysis of the German working group “stereotactic radiotherapy” Juliane Rieber, Jan Streblow, Lorenz Uhlmann, Lung Cancer Adaptive RadiotherapyInoperable Lung Metastases—aRadiation MedicineRadiation TherapyMedicine	2016	157
Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy Matthias Gückenberger, Rainer J. Klement, Michael Allgäuer, Radiotherapy and Oncology Adaptive RadiotherapyRadiation TherapyMedicineSecondary Lung TumorsRadiation Therapy Planning	2015	123
Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study Christopher P. Cifarelli, Stefanie Brehmer, John A. Vargo, Journal of Neuro-Oncology Neuro-oncologySurgical OncologyBrain MetastasesRadiation TherapyMedicine	2019	59
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma—a multicenter analysis of the German working group “Stereotactic Radiotherapy” Juliane Hoerner‐Rieber, Marciana Nona Duma, Oliver Blanck, Journal of Thoracic Disease	2017	51
Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease Juliane Rieber, Nasrin Abbassi-Senger, Sonja Adebahr, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation MedicineTechnological AdvancesRadiation TherapyMedicine	2016	47
Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT Juliane Hörner‐Rieber, Denise Bernhardt, Oliver Blanck, Clinical Lung Cancer Oligometastatic Nsclc TreatedAdvanced Lung DiseasePulmonary SbrtSurgeryMedicine	2019	45
Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy Rainer J. Klement, Juliane Hoerner‐Rieber, Sonja Adebahr, Radiotherapy and Oncology Adaptive RadiotherapyRadiation MedicineRadiation TherapyMultiple Pulmonary OligometastasesMedicine	2018	44
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis Daniel Buergy, Florian Würschmidt, Eleni Gkika, International Journal of Cancer Adaptive RadiotherapySurgical OncologyRadiation MedicineRadiation TherapyMulticenter Analysis	2021	34
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma Stephanie Kroeze, Corinna Fritz, Jana Schaule, British Journal of Urology	2020	30
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database Stephanie Kroeze, Jana Schaule, Corinna Fritz, Radiation Oncology	2021	29

Page 1